Zylox-Tonbridge Medical Technology Co., Ltd. announced that ZENFLEX® Peripheral Stent System, independently developed in-house by the Company, completed the enrollment of all 100 patients in the multi-center clinical trial in Germany. The clinical trial is a prospective, multi-center, single arm study to evaluate the effectiveness and safety of ZENFLEX®®? Peripheral StENT System for adjunctive angioplasty in the treatment of peripheral arterial disease.

The study was coordinated by a world-renowned vascular intervention expert, Professor Dierk Scheinert of the University of Leipzig Medical Center, with the participation of vascular intervention clinicians from five hospitals in Europe.